Navigation Links
Fertility Solutions Welcomes a New Doctor, Dr. Vasiliki Moragianni
Date:6/3/2013

Boston, MA (PRWEB) June 03, 2013

Fertility Solutions is proud to introduce Dr. Vasiliki Moragianni, the newest addition to its renowned, all-female team of fertility specialists. Founded by Dr. Carol Anania, Dr. Ania Kowalik and Dr. Pei-Li Huang, Fertility Solutions was created with the goal of helping patients experience the miracle of life through intelligent, affordable and truly personal fertility care. Dr. Moragianni, is an award-winning fertility doctor and an excellent addition to the team.

Dr. Moragianni graduated from Cornell University with a Bachelor of Science in Human Biology and received her medical degree from Drexel University College of Medicine. She completed her OB/GYN residency at Abington Memorial Hospital and her Reproductive Endocrinology & Infertility fellowship in Boston, at Harvard Medical School and Beth Israel Deaconess Medical Center.

Dr. Moragianni has extensive experience working with patients from around the world as the former Director of the International Patient Program at Boston IVF. A native of Greece, she speaks Greek as well as French, basic Italian and Albanian. She has published numerous peer reviewed articles and is involved in several translational research projects and presentations around the world.

“Infertility is a significant medical problem that affects many couples and individuals. Working with these patients, all uniquely different, to explore their options and help them build their family is the most rewarding experience of my life. I am excited to go to work every day so that I can meet new patients who can benefit from my experience, as well as interact with established patients whom I build long-lasting relationships with. I feel truly fortunate to be able to take care of each and every one of my patients on a daily basis.” – Dr. Moragianni

Her specialties include assisted reproductive techniques such as IVF, ICSI, PGD, IUI and more. Dr. Moragianni has also taken a special interest in helping patients with reproductive endocrine disorders who might not be ready to conceive yet, but want children in the future.

“Dr. Moragianni is a compassionate fertility doctor who believes in the importance of designing individualized treatment plans. As a multilingual physician with distinguished medical abilities, she will be of great help to our patients. We are fortunate to have her on our team.” – Dr. Ania Kowalik

Dr. Moragianni will be seeing patients at the Dedham, Woburn and Providence offices of Fertility Solutions.

About Fertility Solutions:

Fertility Solutions is a premiere fertility center headquartered just outside Boston, Massachusetts with satellite offices throughout New England. The ‘Top Doctors’ of Fertility Solutions have decades of clinical experience. Dr. Carol Anania, Dr. Ania Kowalik, Dr. Pei-Li Huang and Dr. Vasiliki Moragianni provide compassionate care and comprehensive fertility treatments including IVF, PGD, ICSI, IUI, egg donation, surrogacy, fertility preservation, tubal reversal and more.

Learn more about Fertility Solutions at http://www.FertilitySolutionsNE.com or attend a free fertility seminar.

Read the full story at http://www.prweb.com/releases/boston/fertilitysolutions_doctor/prweb10790729.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Men and women receive different fertility advice following cancer diagnosis
2. Men and Women With Cancer May Receive Different Fertility Information
3. Could Fertility Drugs Make Kids Shorter?
4. Under Right Conditions, Fertility Treatment Can Equal Natural Conception Rates: Study
5. Success of fertility treatment may approach natural birth rate
6. Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders
7. Heavy Coffee Intake May Affect Fertility Treatments: Study
8. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
9. Can Fertility Treatments Influence Later Breast Cancer Risk?
10. Fertility drug usage and cancer risk
11. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... , ... David J. Dykeman , Ginger Pigott , and ... at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg ... global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... 10.2 version gives development continuity to its innovative Unified Instance Manager architecture, ... capacity. In addition, this new version optimizes the unattended auto-dialing system without ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to ... convenient service for Texas, they are expanding their presence in Dallas. One of the ... that will bring new jobs to the Dallas and Forth Worth market. STAT takes ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and the Affordable Care Act. Dr. Botelho advocates for the mass media launching ... movement gives people ongoing opportunities to share their unfortunate experiences; such a movement ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... to grow in 2017-2023. Various reasons for growth of ... population, higher incidences of chronic diseases, high recovery cost ... aid services. Medical lifting sling refers to an ... limited mobility. These slings connect to the lift and ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology: